{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:28:05Z","timestamp":1786357685946,"version":"build-2736575974"},"reference-count":49,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare vasculitis. A key bio-logical hallmark is peripheral blood eosinophilia while antineutrophil cytoplasmic an-tibody (ANCA) positivity is not always present. Therefore, an early phase suspicion of EGPA leading to a correct diagnosis can be challenging. We performed an observa-tional cross-sectional study limited to baseline data on 38 patients between December 2019 and December 2025 at the Allergy and Clinical Immunology Unit, Messina, Italy. Data collection included eosinophil, neutrophil, and lymphocyte counts; ANCAs and antinuclear antibodies (ANAs); erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) determination; and the Birmingham vasculitis activity score (BVAS) questionnaire: Median eosinophil counts were 685 cells\/\u00b5L, the neutro-phil-to-lymphocyte ratio (NLR) was 2.29, ESR median values were 24 mm\/h, and CRPs were 1.99 mg\/L. ANCAs were positive in five patients, and ANAs in 20. The trend in ANA+ patients was of lower median eosinophil counts and higher ESR and CRP me-dian values and median BVASs. General, nervous system, and ENT BVAS domains had higher scores.: Disease activity in EGPA at diagnosis can be difficult to recognize. We defined it as chameleon-like and could not be captured by specific immunological sig-natures. Therefore, an early diagnosis needs multidimensional assessment, integrating laboratory parameters with clinical scores. In our EGPA cohort, ANAs were detected in just over half the patients, suggesting that rather than acting as bystanders, these could help clinicians, together with eosinophil counts, NLRs, and BVASs, to suspect EGPA at an early stage for referral to specialized medical centers.<\/jats:p>","DOI":"10.3390\/ijms27167116","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:24:53Z","timestamp":1786353893000},"page":"7116","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["EGPA at Diagnosis: A Comprehensive Single-Center Profile of Laboratory Findings and Clinical Evidence"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2855-254X","authenticated-orcid":false,"given":"Silvia","family":"Brunetto","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Allergy and Clinical Immunology Unit, \u201cG. Martino\u201d Hospital, University of Messina, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1442-9147","authenticated-orcid":false,"given":"Francesca","family":"Dimasi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Allergy and Clinical Immunology Unit, \u201cG. Martino\u201d Hospital, University of Messina, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5267-0851","authenticated-orcid":false,"given":"Cristiano","family":"Maiolo","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Allergy and Clinical Immunology Unit, \u201cG. Martino\u201d Hospital, University of Messina, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6326-8547","authenticated-orcid":false,"given":"Emanuela","family":"Zumbo","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Allergy and Clinical Immunology Unit, \u201cG. Martino\u201d Hospital, University of Messina, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8582-4008","authenticated-orcid":false,"given":"Federica","family":"Buta","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Allergy and Clinical Immunology Unit, \u201cG. Martino\u201d Hospital, University of Messina, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Gangemi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Allergy and Clinical Immunology Unit, \u201cG. Martino\u201d Hospital, University of Messina, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3105-8347","authenticated-orcid":false,"given":"Luisa","family":"Ricciardi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Allergy and Clinical Immunology Unit, \u201cG. Martino\u201d Hospital, University of Messina, 98124 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lo Gullo, A., Giuffrida, C., Morace, C., Squadrito, G., Lio, P.M.S., Ricciardi, L., Salvarani, C., and Mandraffino, G. (2022). Arterial Stiffness and Adult Onset Vasculitis: A Systematic Review. Front. Med., 9.","DOI":"10.3389\/fmed.2022.824630"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Fagni, F., Bello, F., and Emmi, G. (2021). Eosinophilic Granulomatosis With Polyangiitis: Dissecting the Pathophysiology. Front. Med., 8.","DOI":"10.3389\/fmed.2021.627776"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5114\/reum\/196141","article-title":"A variety of clinical presentations of eosinophilic granulomatosis with polyangiitis: A comprehensive review","volume":"62","author":"Sebastian","year":"2024","journal-title":"Rheumatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nrrheum.2014.98","article-title":"Eosinophils in vasculitis: Characteristics and roles in pathogenesis","volume":"10","author":"Khoury","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Watanabe, R., and Hashimoto, M. (2023). Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations. J. Clin. Med., 12.","DOI":"10.3390\/jcm12185996"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"del Pozo, V., Bobolea, I., Rial, M.J., Espigol-Frigol\u00e9, G., Laqu\u00e9, R.S., Hern\u00e1ndez-Rivas, J.M., Mora, E., Crespo-Lessmann, A., Alonso, J.L.I., and Sosa, M.S.D. (2024). Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1310211"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Matucci, A., Vivarelli, E., Perlato, M., Mecheri, V., Accinno, M., Cosmi, L., Parronchi, P., Rossi, O., and Vultaggio, A. (2023). EGPA Phenotyping: Not Only ANCA, but Also Eosinophils. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030776"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Piga, M.A., Fraticelli, P., Antonicelli, L., Garritani, M.S., Ghirelli, G., Martini, M., Di Vincenzo, A., Danieli, M.G., Moroncini, G., and Bil\u00f2, M.B. (2023). ANCA-negative EGPA: Only eosinophils without vasculitis? Insights from anti-T2 biologics. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1325299"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4283928","DOI":"10.1155\/2024\/4283928","article-title":"Clinical Characteristics of EGPA Patients in Comparison to GPA Subgroup with Increased Blood Eosinophilia from POLVAS Registry","volume":"2024","author":"Drynda","year":"2024","journal-title":"J. Immunol. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.55563\/clinexprheumatol\/08k9af","article-title":"Autoantibody profile in eosinophilic granulomatosis and polyangiitis: Predominance of anti-alpha-enolase antibodies","volume":"39","author":"Laskari","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Irure-Ventura, J., and L\u00f3pez-Hoyos, M. (2022). The Past, Present, and Future in Antinuclear Antibodies (ANA). Diagnostics, 12.","DOI":"10.3390\/diagnostics12030647"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Brunetto, S., Buta, F., Gangemi, S., and Ricciardi, L. (2025). Immunological Markers Associated with Skin Manifestations of EGPA. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157472"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0140-6736(23)01736-1","article-title":"Diagnosis and management of ANCA-associated vasculitis","volume":"403","author":"Kronbichler","year":"2024","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40120-021-00315-7","article-title":"ANCA-Associated Vasculitic Neuropathies: A Review","volume":"11","author":"Koike","year":"2022","journal-title":"Neurol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"D\u2019Onofrio, M., La Prova, D., Galdiero, M.R., Cantone, E., Tremante, E., Mascolo, M., Barbieri, V., Di Nola, C., Spadaro, G., and de Paulis, A. (2023). Early Ear, Nose and Throat Manifestations in Eosinophilic Granulomatosis with Poliangioitis: Results from Our Cohort Group and Literature Review. J. Clin. Med., 12.","DOI":"10.20944\/preprints202309.1374.v1"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/03009742.2025.2572885","article-title":"Myeloperoxidase\u2013anti-neutrophil cytoplasmic antibody positivity and disease characteristics, treatment, and prognosis in eosinophilic granulomatosis with polyangiitis","volume":"55","author":"Fukui","year":"2025","journal-title":"Scand. J. Rheumatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2500\/aap.2022.43.220056","article-title":"Benralizumab in the management of rare primary eosinophilic lung diseases","volume":"43","author":"Bennici","year":"2022","journal-title":"Allergy Asthma Proc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.akdh.2024.04.005","article-title":"ANCA-Associated Vasculitis","volume":"31","author":"Sharma","year":"2024","journal-title":"Adv. Kidney Dis. Health"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11886-025-02258-z","article-title":"Cardiac Involvement in Eosinophilic Granulomatosis with Polyangiitis","volume":"27","author":"Srikantharajah","year":"2025","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Li, R., Chen, Y., Zhang, S., Peng, L., Zhou, J., Fei, Y., Zhang, W., Zhao, Y., and Zeng, X. (2023). Clinical characteristics and long-term outcome of patients with gastrointestinal involvement in eosinophilic granulomatosis with polyangiitis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1099722"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/acr2.11571","article-title":"Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis for Patients With and Without a Vasculitic Phenotype","volume":"5","author":"Terrier","year":"2023","journal-title":"ACR Open Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Lazzeroni, M., Longoni, V., Schiavo, P., Bizzi, E., Brucato, A., Gramellini, G., Borin, M., Dragonetti, A., Gaffuri, M., and Lentini, M. (2025). Anti-IL5\/IL-5 receptor therapies for eosinophilic granulomatosis with polyangiitis: An updated Systematic Review. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1587158"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Desaintjean, C., Ahmad, K., Traclet, J., Gerfaud-Valentin, M., Durel, C.-A., Glerant, J.-C., Hot, A., Lestelle, F., Mainbourg, S., and Nasser, M. (2024). Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1341310"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejim.2024.06.008","article-title":"Red flags for clinical suspicion of eosinophilic granulomatosis with polyangiitis (EGPA)","volume":"128","author":"Aparicio","year":"2024","journal-title":"Eur. J. Intern. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41584-025-01306-w","article-title":"Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitis","volume":"21","author":"Merkel","year":"2025","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2500\/aap.2023.44.220072","article-title":"Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible","volume":"44","author":"Zhao","year":"2023","journal-title":"Allergy Asthma Proc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jaip.2025.10.051","article-title":"Early diagnosis and treatment in patients with eosinophilic granulomatosis with polyangiitis","volume":"14","author":"Siddiqui","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"103219","DOI":"10.1016\/j.autrev.2022.103219","article-title":"Eosinophilic granulomatosis with polyangiitis: A review","volume":"22","author":"White","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/00325481.2022.2102368","article-title":"ANCA associated vasculitis (AAV): A review for internists","volume":"135","author":"Yaseen","year":"2023","journal-title":"Postgrad. Med."},{"key":"ref_32","first-page":"4937","article-title":"Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: Data from a European multicentre study","volume":"64","author":"Delvino","year":"2025","journal-title":"Rheumatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa2311155","article-title":"Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis","volume":"390","author":"Wechsler","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"17534666251318615","DOI":"10.1177\/17534666251318615","article-title":"Heterogeneity and individualized therapy for eosinophilic granulomatosis with polyangiitis","volume":"19","author":"Hua","year":"2025","journal-title":"Ther. Adv. Respir. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2500\/108854199778681486","article-title":"Eosinophil Active Cytokines and Surface Analysis of Eosinophils in Churg-Strauss Syndrome","volume":"20","author":"Tsukadaira","year":"1999","journal-title":"Allergy Asthma Proc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2010.03.028","article-title":"Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome","volume":"125","author":"Kim","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.7326\/0003-4819-155-5-201109060-00026","article-title":"Targeting Interleukin-5 in Refractory and Relapsing Churg\u2013Strauss Syndrome","volume":"155","author":"Moosig","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0002-9440(10)65191-7","article-title":"Involvement of Soluble CD95 in Churg-Strauss Syndrome","volume":"155","author":"Warskulat","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/1529-0131(200102)44:2<469::AID-ANR66>3.0.CO;2-0","article-title":"Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome","volume":"44","author":"Kiene","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0b013e32834d85ce","article-title":"Churg\u2013Strauss syndrome","volume":"24","author":"Vaglio","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri3341","article-title":"Eosinophils: Changing perspectives in health and disease","volume":"13","author":"Rosenberg","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Fijolek, J., and Radzikowska, E. (2023). Eosinophilic granulomatosis with polyangiitis\u2014Advances in pathogenesis, diagnosis, and treatment. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1145257"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/tjem.tjem_198_23","article-title":"Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: An extensive literature review","volume":"24","author":"Islam","year":"2024","journal-title":"Turk. J. Emerg. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e23885","DOI":"10.1002\/jcla.23885","article-title":"Novel mortality-predicting index at diagnosis can effectively predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"35","author":"Do","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41584-023-00958-w","article-title":"Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis","volume":"19","author":"Emmi","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.revmed.2025.06.017","article-title":"Manifestations oto-rhino-laryngologiques au cours des vascularites associ\u00e9es aux ANCA","volume":"46","author":"Rouau","year":"2025","journal-title":"Rev. Med. Interne"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Martino, G., Di Giuseppe, M., Silvestro, O., Vicario, C.M., Giorgianni, C.M., Ruggeri, P., Sparacino, G., Juli, M.R., Schwarz, P., and Lingiardi, V. (2025). Defense mechanisms in immune-mediated diseases: A cross-sectional study focusing on Severe Allergic Asthma and Hymenoptera Venom Anaphylaxis patients. Front. Psychol., 16.","DOI":"10.3389\/fpsyg.2025.1608335"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1080\/14656566.2023.2216379","article-title":"Advances in the pharmacotherapeutic management of eosinophilic granulomatosis with polyangiitis","volume":"24","author":"Pagnoux","year":"2023","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/art.41982","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis","volume":"74","author":"Grayson","year":"2022","journal-title":"Arthritis Rheumatol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7116\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:30:33Z","timestamp":1786354233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":49,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27167116"],"URL":"https:\/\/doi.org\/10.3390\/ijms27167116","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]}}}